MED23 anticorps (N-Term)

N° du produit ABIN7188664

Détail du produit anti-MED23 anticorps

Antigène: MED23 (Mediator Complex Subunit 23 (MED23))

Épitope: N-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp MED23 est non-conjugé

Application: ELISA, Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)

Réactivité croisée: Humain, Souris, Rat

Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Immunogène: Synthesized peptide derived from the N-terminal region of Human CRSP130.

Isotype: IgG

Information d'application

Indications d'application: WB:1:500-1:2000, IHC:1:100-1:300, IF:1:200-1:1000, ELISA:1:5000,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur MED23

Antigène: MED23 (Mediator Complex Subunit 23 (MED23))

Autre désignation: MED23 (MED23 Produits)

Synonymes: anticorps CG3695, anticorps Dmel\\CG3695, anticorps Gal11/SUR2, anticorps Med23, anticorps Trap150, anticorps Trap150beta, anticorps dSUR2, anticorps dTRAP150beta, anticorps CRSP3, anticorps MED23, anticorps ARC130, anticorps CRSP130, anticorps CRSP133, anticorps DRIP130, anticorps MRT18, anticorps SUR-2, anticorps SUR2, anticorps 130kDa, anticorps 3000002A17Rik, anticorps Crsp3, anticorps ESTM7, anticorps Sur2, anticorps X83317, anticorps mKIAA1216, anticorps crsp3, anticorps si:ch211-272f15.2, anticorps zgc:91979, anticorps Mediator complex subunit 23, anticorps mediator complex subunit 23, anticorps mediator of RNA polymerase II transcription subunit 23, anticorps mediator complex subunit 23 L homeolog, anticorps Mediator of RNA polymerase II transcription subunit 23, anticorps MED23, anticorps med23, anticorps LOC412332, anticorps Med23, anticorps med23.L, anticorps sur-2

Sujet: 130 kDa transcriptional co activator antibody, 133 kDa transcriptional co activator antibody, Activator recruited cofactor 130 kDa component antibody, Activator-recruited cofactor 130 kDa component antibody, ARC 130 antibody, ARC130 antibody, Cofactor required for Sp1 transcriptional activation subunit 3 130 kDa antibody, Cofactor required for Sp1 transcriptional activation subunit 3 130 kDa mediator antibody, Cofactor required for Sp1 transcriptional activation subunit 3 antibody, CRSP 130 antibody, CRSP 130 kD subunit antibody, CRSP 133 antibody, CRSP 3 antibody, CRSP complex subunit 3 antibody, CRSP130 antibody, CRSP133 antibody, CRSP3 antibody, CRSP3 protein antibody, DKFZp434H0117 antibody, DRIP 130 antibody, DRIP130 antibody, hSur-2 antibody, KIAA1216 antibody, MED 23 antibody, med23 antibody, MED23_HUMAN antibody, Mediator complex subunit 23 antibody, Mediator of RNA polymerase II transcription subunit 23 antibody, MRT18 antibody, Protein sur-2 homolog antibody, SUR 2 antibody, SUR2 antibody, Transcriptional co activator CRSP 130 antibody, Transcriptional co activator CRSP130 antibody, Transcriptional coactivator CRSP130 antibody, Vitamin D3 receptor interacting protein antibody, Vitamin D3 receptor interacting protein complex 130 kDa component antibody, Vitamin D3 receptor-interacting protein complex 130 kDa component antibody

UniProt: Q9ULK4

Pathways: Regulation of Lipid Metabolism by PPARalpha